CELU GoodMoat Verdict
Full signal breakdown coming soon. Use the X-Ray tool for a detailed analysis.
Celularity Inc - Class A
Exchange: NASDAQSector: HealthcareIndustry: Biotechnology
Did you know?
CELU's revenue grew at a 3.9% CAGR over the last 6 years.
Current Price
$0.98
+2.83%Profile
Valuation (TTM)
Market Cap$27.88M
P/E-0.30
EV—
P/B—
Shares Out28.33M
P/Sales1.05
Revenue$26.55M
EV/EBITDA—
Celularity Inc - Class A (CELU) Quality Analysis
CELU Profitability
Profitability trend analysis coming soon
CELU Growth
Growth trend analysis coming soon
CELU Financial Health
Financial health indicators coming soon
CELU Quality & Fundamental Analysis
Celularity Inc - Class A (CELU) is a Healthcare company in the Biotechnology industry, listed on NASDAQ. This quality analysis page evaluates Celularity Inc - Class A's financial health using the Piotroski F-Score methodology, profitability ratios, growth trajectory, and balance sheet strength.
Celularity Inc - Class A has a Piotroski F-Score of N/A out of 9, measuring profitability, leverage, and operating efficiency. The company operates with a profit margin of -345.45%. Return on assets (ROA) stands at -85.45%.
with a current ratio of 0.15. Operating margin is -230.92%.
GoodMoat's quality analysis uses AI-powered insights to evaluate whether Celularity Inc - Class A is a fundamentally sound investment. The GoodMoat Verdict synthesizes profitability, growth, and financial health scores into a clear investment quality rating. Use these metrics alongside valuation tools like the DCF calculator and fair value models to make informed investment decisions.